PRJNA278887
BT474 48h Lapatinib+JQ1 transcriptome response
This experiment evaluated the transcriptome response of the SKBR3 HER2-positive breast cancer cell line to 48 hours treatment with 300nM lapatinib, 300nM JQ1, or the combination treatment, relative to a DMSO-only control.